Israel’s MeMed (see here previously) has been awarded nearly $727,800 from the US Biomedical Advanced Research and Development Authority (BARDA) to support a trial of its 15-minute MeMed BV test that distinguishes between bacterial and viral infections. https://www.me-med.com/press_release/memed-awarded-us-barda-contract/

The European Innovation Council has just added 2.5 million Euros to international funds that Israel’s MeMed previously received (see here) to roll out its test that distinguishes between a virus and a bacteria. Very timely for World Antibiotic Awareness Week … Continue reading →

The US Department of Defense has awarded a $9.2 million contract to Israel’s MeMed to help it complete its pioneering platform for distinguishing bacterial from viral infections. MeMed (see here) had already received a 2.3 million Euro grant from the … Continue reading →

The UN has prioritized fighting antibiotic resistance. Meanwhile, the European Commission has granted 2.3 million Euros to Israeli biotech MeMed to help develop its fast blood test that distinguishes between bacterial and viral infections – and thus significantly reduces the … Continue reading →